Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Clinical Trials
Sponsors / Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The ClinicalTrials.gov registry records 139 trials led by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Across the portfolio, 11 are in recruitment, 7 are active non-recruiting, and 76 have reached completion. 41 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Across the portfolio, planned enrollment totals 12,864 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
139
Total Trials
11
Recruiting
7
Other Active
76
Completed
41
Terminated / Withdrawn
12,864
Total Enrollment
Termination reasons: Recruitment51% · Other27% · Funding10% · Efficacy7% · Safety2% · Regulatory2%
Recent Terminations
- NCT06122480 Stopped Apr 2026Oligometastatic Disease"Study team no longer available to support recruitment and enrollment activities."
- Systemic Sclerosis"This study was closed due to low accrual"
- Renal Cell Carcinoma Metastatic"Study terminated due to lack of funding"
- Pancreas Cancer"Technical difficulties that were not able to be resolved."
- NCT04895553 Stopped Aug 2022Glioma, Malignant"lack of funds. Only 1 patient was enrolled"
- Coronavirus Infection"PI Decision to close/stop the study due to no new accrual."
- Prostate Cancer"lack of accrual"
- Breast Cancer Diagnosis"Inadequate FNA samples (low cell counts)"
- Multiple Myeloma"MEDI-551 removed from oncology by pharmaceutical company due to change in research target."
- Glioma"Imaging results were not sufficient or of good quality; therefore, we will not move further with the project."
Active Trials (7 total)
- Melanoma NANCT05121545
- NCT05995821
- Bladder Cancer PHASE2NCT05656235
- Leptomeningeal Disease PHASE2NCT02422641
- NCT06138067
- NCT01607008
- Non-Small Cell Lung Cancer PHASE1NCT05254184
- Bladder Cancer PHASE2NCT04386746
- Pancreatic Cancer PHASE2NCT01088789
- Pancreatic Cancer PHASE1NCT05141513
- NCT07062549
- NCT02743910
- NCT04363164
- NCT03223922
- NCT04376229
- Acute Myeloid Leukemia PHASE1NCT05716009
- NCT01937039
- NCT06803745